← Russell 3000 cross-section

WAY Waystar Holding Corp.

Trailing twelve months to 2026-06-30 · as filed 2026-07-29, not restated
Technology

Scale

Market cap
$4.9bn
Revenue TTM
$1.2bn
Net income TTM
$135m
Free cash flow
$246m
Composite score
45.5
Sector rank
#1091

Valuation

P / E
36.4
EV / EBITDA
14.3
EV / sales
5.1
FCF yield
5.01%
Earnings yield vs 10-yr
-1.99pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
11.2%
EBITDA margin
35.9%
ROE
3.4%
ROIC
5.3%
Revenue growth

Insider activity, last 90 days

Net open-market
$-3.68m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Revenue Recognition We derive revenue primarily from providing access to our solutions for use in the healthcare industry and in doing so generate two types of revenue: (i) subscription revenue and (ii) volume-based revenue, which account for 99 % of total revenue for all periods presented. Implementation fees and hardware sales represent less than 1 % of total revenue for all periods presented. Contract Costs Incremental Costs of Obtaining a Contract Incremental costs of obtaining a contract primarily include commissions paid to our internal sales personnel. …Waystar Holding Corp., 10-Q, period ended 2026-06-30, filed 2026-07-29

Read the full passage →